LIAISON® CEA
Mexico·Clase II·III. DIAGNOSTIC AGENTS·DIASORIN MÉXICO S.A. DE C.V.·Registered December 13, 2019REACTIVOS PARA LA DETERMINACIÓN CUANTITATIVA DE ANTÍGENO CARCINOEMBRIONARIO (CEA)
REAGENTS FOR THE QUANTITATIVE DETERMINATION OF CARCINOEMBRYONIC ANTIGEN (CEA)
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVOS PARA LA DETERMINACIÓN CUANTITATIVA DE ANTÍGENO CARCINOEMBRIONARIO (CEA)
- Trade Name (English)
- REAGENTS FOR THE QUANTITATIVE DETERMINATION OF CARCINOEMBRYONIC ANTIGEN (CEA)
- Analysis ID
- 2261R2019 SSA
- Registration Date
- December 13, 2019
- Name (Spanish)
- DIASORIN MÉXICO S.A. DE C.V.
- Name (English)
- DIASORIN MEXICO S.A. DE C.V.
Access comprehensive regulatory information for LIAISON® CEA (LIAISON® CEA) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 2261R2019 SSA and manufactured by DIASORIN MÉXICO S.A. DE C.V.. The device was registered on December 13, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.